In addition, Nasarre et al. found that Nrp1 antagonist peptides that target the Nrp1 transmembrane domain can effectively prevent the growth of rat and human gliomas in the body by inhibiting VEGF signaling and may prolong the survival time of patients with glioma [36]. The gene discussed is VEGFA; the disease is glioma.